Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 8,649 | 10,434 | 6,753 | 6,764 | 13,451 |
| Cost of Goods | 1,860 | 1,120 | 1,930 | 1,370 | 1,880 |
| Gross Profit | 6,810 | 9,300 | 4,810 | 5,390 | 11,590 |
| Operating Expenses | 9,960 | 8,180 | 9,390 | 10,640 | 10,420 |
| Operating Income | -2,311 | 1,254 | -3,637 | -4,876 | 2,031 |
| Interest Expense | 0 | 0 | 0 | 0 | 20 |
| Other Income | 271 | 496 | 247 | -24 | 769 |
| Pre-tax Income | -2,040 | 1,750 | -3,390 | -4,900 | 2,780 |
| Income Tax | 70 | 40 | 60 | 20 | 100 |
| Net Income Continuous | -2,091 | 1,703 | -3,459 | -4,927 | 2,678 |
| Net Income | $-2,091 | $1,703 | $-3,459 | $-4,927 | $2,678 |
| EPS Basic Total Ops | -0.08 | 0.07 | -0.14 | -0.20 | 0.11 |
| EPS Basic Continuous Ops | -0.08 | 0.07 | -0.14 | -0.20 | 0.11 |
| EPS Diluted Total Ops | -0.08 | 0.07 | -0.14 | -0.20 | 0.11 |
| EPS Diluted Continuous Ops | -0.08 | 0.07 | -0.14 | -0.20 | 0.11 |
| EBITDA(a) | $-1,621 | $1,964 | $-2,717 | $-3,856 | $3,201 |